Register  /  Login               
Print this article

Dr. Michael Quirmbach, Chief Business Officer – CordenPharma International 

Keywords:

e-version image

Click HERE to download the PDF version

 

ANY UPDATES ON SOME OF YOUR MOST RECENT KEY STRATEGIC INVESTMENT / EXPANSION PROJECTS?

At the end of 2018 we successfully completed our US$20 million flagship investment in CordenPharma Caponago (IT). The construction resulted in our new commercial aseptic fill and finish injectable plant, consisting of two highly flexible filling lines enabling the manufacture of a broad range of vials, Pre-Filled Syringes (PFS) and cartridges using state-of-the-art nest & tub technology. Both lines have been approved by AIFA and one of the new lines is already operational, with a successful PAI FDA inspection for two products. Overall, the two new lines will increase the manufacturing capacity to 20 million units per year and add expanded lyophilization capacity.

Furthermore, we are in the process of compl ... ...




About us



Teknoscienze publisher
& Event Organizer

Viale Brianza, 22
20127 - Milano - Italy

info@teknoscienze.com
Tel. +39 02 26809375